175 related articles for article (PubMed ID: 6785797)
1. Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
Mendis N; Pare CM; Sandler M; Glover V; Stern GM
Psychopharmacology (Berl); 1981; 73(1):87-90. PubMed ID: 6785797
[TBL] [Abstract][Full Text] [Related]
2. Absence of "cheese effect" during deprenyl therapy: some recent studies.
Sandler M; Glover V; Ashford A; Stern GM
J Neural Transm; 1978; 43(3-4):209-15. PubMed ID: 745013
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
Sandler M; Glover V; Ashford A; Esmail A
J Neural Transm; 1980; 48(4):241-7. PubMed ID: 6775051
[TBL] [Abstract][Full Text] [Related]
4. A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor.
Mann JJ; Aarons SF; Wilner PJ; Keilp JG; Sweeney JA; Pearlstein T; Frances AJ; Kocsis JH; Brown RP
Arch Gen Psychiatry; 1989 Jan; 46(1):45-50. PubMed ID: 2491941
[TBL] [Abstract][Full Text] [Related]
5. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
Glover V; Pycock CJ; Sandler M
Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
[TBL] [Abstract][Full Text] [Related]
6. Tyramine pressor sensitivity changes during deprenyl treatment.
Sunderland T; Mueller EA; Cohen RM; Jimerson DC; Pickar D; Murphy DL
Psychopharmacology (Berl); 1985; 86(4):432-7. PubMed ID: 3929314
[TBL] [Abstract][Full Text] [Related]
7. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
Abdo-Rubo A
Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
[TBL] [Abstract][Full Text] [Related]
8. Effects of a tyramine-enriched meal on blood pressure response in healthy male volunteers treated with selegiline transdermal system 6 mg/24 hour.
Blob LF; Sharoky M; Campbell BJ; Kemper EM; Gilmor MG; VanDenberg CM; Azzaro AJ
CNS Spectr; 2007 Jan; 12(1):25-34. PubMed ID: 17192761
[TBL] [Abstract][Full Text] [Related]
9. Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
Schulz R; Antonin KH; Hoffmann E; Jedrychowski M; Nilsson E; Schick C; Bieck PR
Clin Pharmacol Ther; 1989 Nov; 46(5):528-36. PubMed ID: 2510962
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.
Amsterdam JD
J Clin Psychiatry; 2003 Feb; 64(2):208-14. PubMed ID: 12633131
[TBL] [Abstract][Full Text] [Related]
11. L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition.
Tariot PN; Cohen RM; Sunderland T; Newhouse PA; Yount D; Mellow AM; Weingartner H; Mueller EA; Murphy DL
Arch Gen Psychiatry; 1987 May; 44(5):427-33. PubMed ID: 3107514
[TBL] [Abstract][Full Text] [Related]
12. Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.
Prasad A; Glover V; Goodwin BL; Sandler M; Signy M; Smith SE
Psychopharmacology (Berl); 1988; 95(4):540-3. PubMed ID: 3145523
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
Youdim MB; Weinstock M
Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase inhibitors and the cheese effect.
Anderson MC; Hasan F; McCrodden JM; Tipton KF
Neurochem Res; 1993 Nov; 18(11):1145-9. PubMed ID: 8255365
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase inhibitor efficacy in depression and the "cheese effect".
Sandler M
Psychol Med; 1981 Aug; 11(3):455-8. PubMed ID: 6791195
[No Abstract] [Full Text] [Related]
16. Studies of selective and reversible monoamine oxidase inhibitors.
Mann JJ; Aarons SF; Frances AJ; Brown RD
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
[TBL] [Abstract][Full Text] [Related]
17. Tyramine infusions and selective monoamine oxidase inhibitor treatment. I. Changes in pressor sensitivity.
Pickar D; Cohen RM; Jimerson DC; Murphy DL
Psychopharmacology (Berl); 1981; 74(1):4-7. PubMed ID: 6791202
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
19. L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation.
Mendlewicz J; Youdim MB
Br J Psychiatry; 1983 May; 142():508-11. PubMed ID: 6409196
[TBL] [Abstract][Full Text] [Related]
20. Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.
Finberg JP; Youdim MB
Br J Pharmacol; 1985 Jun; 85(2):541-6. PubMed ID: 3928010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
